TrialPay is now LIVE on select RevenueWire products

TrialPay is now LIVE on select RevenueWire products

BIG-TIME NEWS! TrialPay is now LIVE on Paretologic’s Regcure, DriverCure and Paretologic Antivirus products.

What does this mean? In short… MORE REVENUE FOR YOU.

TrialPay’s transactional advertising model uses the efficiencies of the Web to pair online shoppers with ideal products at every stage of the purchase process. Lost revenue opportunities due to customer bail out will now be transformed into increased revenue through the TrialPay system.

With TrialPay’s “Get It Free” model, a customer can get a product for FREE by completing one offer from some of the biggest brands in the world.

So here’s how it works…

Any end users that click the “back” button (called bailing out) from a SafeCart purchase will be redirected to TrialPay – where they can get the product for “FREE” (e.g., RegCure) by buying any one of a number of product offers from major brand names. For example a customer might get RegCure for free by buying ink cartridges or using FreeCreditReport.com through TrialPay.

The offer settlements vary, but affiliates will receive 50% of the offer settlement (minus Revenuewire’s share).

Some of TrialPay’s partners include:
• FTD
• BLOCKBUSTER
• DISCOVER
• GAP
• REALPLAYER
• FANDANGO
• AND MORE

trialpay-logos

TrialPay increases the probability of conversion and maximizes the profit of each transaction for any online seller. It works with name-brand companies across numerous verticals, and offers 25 million registered users more than 2,000 ways to pay through premier advertisers.

This is, essentially, extra money over and above your existing conversion rates, with some affiliates already seeing these commissions show up in their sales reports.

Share and Enjoy:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • BlinkList
  • FriendFeed
  • LinkedIn
  • NewsVine
  • Reddit
  • StumbleUpon
  • Technorati
  • Yahoo! Buzz
  • Tumblr
  • Yahoo! Bookmarks
  • Twitter

Related Articles

  • No Related Post


Leave a Reply